Drug application
FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F-18)
Drugs@FDA ANDA 203994 · NORTHLAND
Key facts
| Drug name | FLUDEOXYGLUCOSE F18 |
|---|---|
| Active ingredients | FLUDEOXYGLUCOSE F-18 |
| Application type | ANDA |
| Application number | 203994 |
| Company | NORTHLAND |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | 4-500mCi/ML |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Feb 4, 2015 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.